Pulike Biological announces interim dividend, cash management plans

Pulike Biological Engineering will distribute a cash dividend of CNY 2 per 10 shares (including tax) for the first half of 2025. The total cash dividend is projected to be CNY 68,383,874.60, based on the total share capital as of June 30, 2025, after deducting shares in the buyback special account. This distribution represents 58.86% of the net profit attributable to shareholders and 8.64% of the cumulative distributable profit for the period.

The company also plans to use up to CNY 210m of temporarily idle raised funds and CNY 250m of idle own funds for cash management. These funds will be invested in highly secure, liquid, principal-protected wealth management products, such as large-denomination certificates of deposit, for a period not exceeding 12 months. This strategy aims to enhance capital efficiency and increase investment returns while ensuring project progress and capital security.

These proposals were approved by the board of directors and the supervisory board on August 28, 2025, with the dividend plan requiring shareholder approval. A performance briefing will be held on September 15, 2025, to discuss these results and plans.